However, in breast cancer, study showed that downregulation of ATG9B but not its orthologue ATG9A could accelerate breast cancer progression [22], signifying that ATG9A and ATG9B have different biological function in cancer. This evidence concerns the gene ATG9A and breast carcinoma.